Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Study drug QTX3046 for KRAS G12D mutated advanced solid tumors
Clinical Trial Grant
Duke Scholars
Principal Investigator
John Strickler
Medicine, Medical Oncology
Awarded By
Quanta Therapeutics, Inc.
Start Date
November 18, 2024
End Date
December 1, 2029
Awarded By
Quanta Therapeutics, Inc.
Start Date
November 18, 2024
End Date
December 1, 2029
